These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33061322)

  • 1. Impact of Metabolic Syndrome Components in High-Risk Cardiovascular Disease Development in Older Adults.
    Gustavo de Sousa Barbalho Y; Morato Stival M; Ramos de Lima L; Cristina Rodrigues da Silva I; de Oliveira Silva A; Vieira Gomes da Costa M; Cristina Morais Santa Barbara Rehem T; Schwerz Funghetto S
    Clin Interv Aging; 2020; 15():1691-1700. PubMed ID: 33061322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.
    Jahangiry L; Farhangi MA; Rezaei F
    J Health Popul Nutr; 2017 Nov; 36(1):36. PubMed ID: 29132438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
    Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
    Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project.
    Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z
    BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Patients with Cardiovascular Disease Show More Metabolic Syndrome than Nondiabetic Patients: Multicentric Study in the Northeast of Brazil.
    de Brito Gonçalves Nascimento L; Sahade V; Weber B; Pinheiro JMF; Dias LPP; Figueiredo Neto JA; Carlos Sobral Sousa A; Pinho CPS; Luna AB; Vasconcelos SML; Dantas CF; Penafort AM; Carlos DMO; Daltro C
    Metab Syndr Relat Disord; 2021 May; 19(4):233-239. PubMed ID: 33523760
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
    Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
    Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.
    Agyemang-Yeboah F; Eghan BAJ; Annani-Akollor ME; Togbe E; Donkor S; Oppong Afranie B
    Biomed Res Int; 2019; 2019():4562904. PubMed ID: 31187045
    [No Abstract]   [Full Text] [Related]  

  • 9. The Study of Cardiovascular Risk in Adolescents--ERICA: rationale, design and sample characteristics of a national survey examining cardiovascular risk factor profile in Brazilian adolescents.
    Bloch KV; Szklo M; Kuschnir MC; Abreu Gde A; Barufaldi LA; Klein CH; de Vasconcelos MT; da Veiga GV; Figueiredo VC; Dias A; Moraes AJ; Souza AL; de Oliveira AM; Schaan BD; Tavares BM; de Oliveira CL; Cunha Cde F; Giannini DT; Belfort DR; Ribas DL; Santos EL; de Leon EB; Fujimori E; Oliveira ER; Magliano Eda S; Vasconcelos Fde A; Azevedo GD; Brunken GS; Dias GM; Filho HR; Monteiro MI; Guimarães IC; Faria Neto JR; Oliveira JS; de Carvalho KM; Gonçalves LG; Santos MM; Muniz PT; Jardim PC; Ferreira PA; Montenegro RM; Gurgel RQ; Vianna RP; Vasconcelos SM; da Matta SS; Martins SM; Goldberg TB; da Silva TL
    BMC Public Health; 2015 Feb; 15():94. PubMed ID: 25880653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Metabolic Syndrome and Framingham Risk Score in Apparently Healthy Vegetarian and Omnivorous Men.
    Navarro JCA; Antoniazzi L; Oki AM; Bonfim MC; Hong V; Bortolotto LA; Acosta-Cardenas P; Sandrim V; Miname MH; Santos Filho RDD
    Arq Bras Cardiol; 2018 May; 110(5):430-437. PubMed ID: 29898042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination Survey.
    Kang HK; Park HY; Jeong BH; Koh WJ; Lim SY
    Medicine (Baltimore); 2015 Nov; 94(47):e2089. PubMed ID: 26632722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.
    Misra R; Patel T; Kotha P; Raji A; Ganda O; Banerji M; Shah V; Vijay K; Mudaliar S; Iyer D; Balasubramanyam A
    J Diabetes Complications; 2010; 24(3):145-53. PubMed ID: 19303333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Cardiovascular Disease Related to Metabolic Syndrome in College Students: A Cross-Sectional Secondary Data Analysis.
    Jang I; Kim JS
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31581588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study.
    Gronner MF; Bosi PL; Carvalho AM; Casale G; Contrera D; Pereira MA; Diogo TM; Torquato MT; Souza GM; Oishi J; Leal AM
    Braz J Med Biol Res; 2011 Jul; 44(7):713-9. PubMed ID: 21755260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic syndrome in young adults type 1 diabetic patients].
    Szadkowska A; Pietrzak I; Bodalska-Lipińska J; Czerniawska E; Wlodarczyk M; Swatko-Mikolajczyk A; Bodalski J
    Przegl Lek; 2008; 65(3):126-30. PubMed ID: 18624120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of atherogenic dyslipidemia in the development of metabolic syndrome].
    Real JT; Romero P; Martínez Hervas S; Pedro T; Carmena R; Ascaso JF
    Med Clin (Barc); 2006 Sep; 127(9):321-4. PubMed ID: 16987450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.